Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: This study aimed to investigate the potential role of systemic inflammatory markers in the management of Prostate Cancer (PCA) with variant pathology.
Materials And Methods: A retrospective analysis was conducted on 302 patients who underwent radical prostatectomy between 2014 and 2023. After applying exclusion criteria, 279 patients were included: 207 with adenocarcinoma and 72 with variant pathologies. Systemic inflammatory markers such as Neutrophil/Lymphocyte Ratio (NLR), Platelet/Lymphocyte Ratio (PLR), Systemic Immune Inflammation Index (SII), and Systemic Inflammation Response Index (SIRI) were compared between the groups.
Results: In the variant group, the patients were significantly older (p=.005). There were no significant differences in height, weight, and BMI(Body Mass Index), HT(Hypertension), DM(Diabetes Mellitus) and CVD(Cardiovascular Disease) between groups. In the variant histology group, the frequency of LVI(Lymphovascular Invasion) and PNI(Perineural Invasion) were significantly higher (p<.001 and p =.014, respectively). The rates of SM(Surgical Margin) was also significantly higher in the variant group (p<.001). Higher ISUP-grades in prostatectomy specimens were observed in the variant histology group (p<.001)..There were no significant differences between the groups in terms NLR, PLR, SIRI and SII values. Pretreatment PSA values were also significantly higher in the variant group (p < .001), as was the rate of radiotherapy (p < .001). However, no significant differences were found in NLR, PLR, SIRI, or SII values. Recurrence rates and disease-specific survival (DSS) were significantly higher in the variant group(p < .05) though predicted survival duration did not differ.
Conclusion: These results indicate that inflammation markers have limited value in predicting prognosis among variant PCA.It highlights the complex role of inflammation in cancer progression.This study has helped us to better understand the relationship between PCA and inflammation but further research is needed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.22037/uj.v22i.8378 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of the ONSTEP and Lichtenstein techniques for inguinal hernia repair-early results of a prospective study.
Pol Merkur Lekarski
September 2025
DEPARTMENT OF GENERAL, ONCOLOGIC AND METABOLIC SURGERY, INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE, WARSAW, POLAND.
Objective: Aim: The study aims to evaluate the impact of the ONSTEP technique on the intensity of the systemic inflammatory response syndrome (SIRS) and the outcomes of inguinal hernia treatment compared to the Lichtenstein technique. .
Patients And Methods: Materials and Methods: In 41 men randomized into 2 study groups, unilateral inguinal hernia repair was performed using the ONSTEP technique in group O and the Lichtenstein technique in group L.
Peptidylarginine deiminase 4 deficiency alleviates hypoxia/reoxygenation-induced cardiomyocyte injury.
PLoS One
September 2025
Department of Cardiac Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Background: Cardiac ischemia reperfusion (I/R) injury is a serious consequence of reperfusion therapy for myocardial infarction (MI). Peptidylarginine deiminase 4 (PAD4) is a calcium-dependent enzyme that catalyzes the citrullination of proteins. In previous studies, PAD4 inhibition protected distinct organs from I/R injury by preventing the formation of neutrophil extracellular traps (NETs) and attenuating inflammatory responses.
View Article and Find Full Text PDFAssociation of Dry Eye and Corneal Ulcers With Collagen Vascular Diseases in a Medicare Population.
Cornea
September 2025
Icahn School of Medicine at Mount Sinai, Department of Ophthalmology, New York, NY.
Purpose: There is a lack of research on the extent to which non-Sjögren collagen vascular diseases affect the ocular surface. This study aims to understand the associations between collagen vascular diseases and dry eye and corneal ulcers.
Methods: This study analyzed a random 5% sample of national Medicare beneficiaries from 2011 to 2015 and included claims for those with collagen vascular diseases and either dry eye or corneal ulcers (n = 2,688,114).
An Activatable and Covalent Tumor-Associated Antigen Capturer Enabling Systemic Injection for Promoted Antitumor Immunity.
J Am Chem Soc
September 2025
Frontiers Science Center for New Organic Matter, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences and Academy for Advanced Interdisciplinary Studies, Nankai University, Tianjin 300071, PR China.
Antigen-capturing nanomaterials hold great promise for cancer immunotherapy; however, the need for tumor localized administration and limited antigen-binding affinity remains the "Achilles heel" of this strategy. Herein, we present a tumor microenvironment (TME)-activatable nanoplatform, TDR848@FPB, designed for systemic administration and enhanced covalent capture of tumor-associated antigens (TAAs), enabling effective immunotherapy with minimal off-target effects and independent of localized tumor administration. This platform encapsulates a photosensitizer-conjugated, light-activated toll-like receptor (TLR) agonist, which induces immunogenic cell death and triggers a pro-inflammatory TME conducive to antigen capture upon light irradiation.
View Article and Find Full Text PDFFrom Gut Inflammation to Cardiovascular Conflagration: Mapping IBD's Cardiometabolic Risks.
Curr Atheroscler Rep
September 2025
Division of Gastroenterology and Hepatology, Lynda K. and David M. Underwood Center for Digestive Health, Houston Methodist Hospital, Houston, TX, USA.
Purpose Of Review: This review aims to characterize the known cardiovascular (CV) manifestations associated with inflammatory bowel disease (IBD) and the underlying mechanisms driving these associations.
Recent Findings: Gut dysbiosis, a hallmark of patients with IBD, can result in both local and systemic inflammation, thereby potentially increasing the risk of cardiovascular disease (CVD) in the IBD population. Micronutrient deficiencies, anemia, and sarcopenia independently increase the risk of CVD and are frequent comorbidities of patients with IBD.